2024 Volume 63 Issue 2 Pages 79-84
Objective : To investigate the implementation status of rapid on-site cytologic evaluation (ROSE) at cooperating hospitals, and to determine the current status and issues associated with ROSE during bronchoscopy.
Study Design : A questionnaire survey designed to examine the current status of ROSE in bronchoscopy was submitted to 25 hospitals in Hiroshima prefecture and 40 hospitals outside Hiroshima prefecture.
Results : ROSE was performed at 24 out of the 60 hospitals (40%) during bronchoscopy procedures, with “evaluation of the number of atypical cells,” a required part of the ROSE report. Many hospitals that did not implement ROSE answered that “there is shortage of personnel time to devote to ROSE.”
Conclusion : ROSE is performed for diagnosis and genetic testing, but the “medical fees,” “standardization of specimens processing and evaluation criteria,” and “implementation of on the job training” remain issues that need to be addressed in the future.
